Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B John

Showing results (551-560 of 612) with videos related to

Pageof 62
Sort By:
American Heart Journal|June 20, 2006
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424William E Boden, Robert A O'rourke, Koon K Teo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 25, 2022
Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trialJohn J Graham, Akshay Bagai, Harindra Wijeysundera, et al.
The American Journal of Cardiology|January 16, 2007
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialWilliam E Boden, Robert A O'rourke, Koon K Teo, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Coronary CT angiography of patients with a normal body mass index using 80 kVp versus 100 kVp: a prospective, multicenter, multivendor randomized trialTroy M LaBounty, Jonathon Leipsic, Rohan Poulter, et al.
Lancet (London, England)|September 4, 2025
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trialSubodh Verma, Lawrence A Leiter, Hwee Teoh, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
JACC. Cardiovascular Interventions|January 21, 2014
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemiaG B John Mancini, Pamela M Hartigan, Leslee J Shaw, et al.
Clinical Cardiology|April 11, 2018
The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British ColumbiaLiam R Brunham, Kelsey Lynch, Amy English, et al.
CJC Open|November 11, 2024
Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid GuidelineG B John Mancini, Glen J Pearson, Arden R Barry, et al.
Pageof 62

Showing results (551-560 of 612) with videos related to

Sort By:
Pageof 62
American Heart Journal|June 20, 2006
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424William E Boden, Robert A O'rourke, Koon K Teo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 25, 2022
Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trialJohn J Graham, Akshay Bagai, Harindra Wijeysundera, et al.
The American Journal of Cardiology|January 16, 2007
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialWilliam E Boden, Robert A O'rourke, Koon K Teo, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Coronary CT angiography of patients with a normal body mass index using 80 kVp versus 100 kVp: a prospective, multicenter, multivendor randomized trialTroy M LaBounty, Jonathon Leipsic, Rohan Poulter, et al.
Lancet (London, England)|September 4, 2025
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trialSubodh Verma, Lawrence A Leiter, Hwee Teoh, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
JACC. Cardiovascular Interventions|January 21, 2014
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemiaG B John Mancini, Pamela M Hartigan, Leslee J Shaw, et al.
Clinical Cardiology|April 11, 2018
The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British ColumbiaLiam R Brunham, Kelsey Lynch, Amy English, et al.
CJC Open|November 11, 2024
Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid GuidelineG B John Mancini, Glen J Pearson, Arden R Barry, et al.
Pageof 62